Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Read more here
News
Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
Read more here
Optofluidics Awarded NSF Phase IIB SBIR
Read more here
Intezyne Technologies Expands Executive Leadership Team with Two Key Appointments
Read more here
Relmada Therapeutics Files Shares Registration Statement
Read more here
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million in Connection with Going Public Transaction
Read more here
BioAdvance Portfolio Generated $450M in Fiscal 2014
Read more here
HealthQx Expands, Fueled by a New Round of Funding
Read more here
Sean Cunliffe Joins TREVENTIS Corporation as CEO
Read more here
Galleon’s Sleep Apnea Pill Nears Human Tests
Read more here